LYTLE PAUL J 4
4 · Mosaic ImmunoEngineering Inc. · Filed Dec 16, 2020
Insider Transaction Report
Form 4
LYTLE PAUL J
DirectorEVP, Chief Financial Officer10% Owner
Transactions
- Award
Restricted Stock Units
2020-12-16$3.30/sh+37,772$124,648→ 80,164 totalFrom: 2022-08-31→ Common Stock (37,772 underlying) - Award
Restricted Stock Units
2020-12-16$3.30/sh+42,392$139,894→ 42,392 totalFrom: 2021-08-31→ Common Stock (42,392 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]RSU's granted under the Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan as part of the reporting person's annual base salary. RSUs will vest 100% on August 31, 2021, subject to the reporting person's continuous service to the Issuer on such vesting date.
- [F3]RSU's granted under the Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan as a long-term incentive grant equal to 25% of reporting person's annual base salary. RSUs will vest 100% on August 31, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date.